Larkspur Health Acquisition Corp.
Larkspur Health Acquisition Corp. (LSPR) Stock Overview
Explore Larkspur Health Acquisition Corp.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
204.3M
P/E Ratio
-0.00
EPS (TTM)
N/A
ROE
-1.12%
LSPR Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Larkspur Health Acquisition Corp. (LSPR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $173.90.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 204.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Larkspur Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on business in the biotechnology sector in the United States. The company was incorporated in 2021 and is based in Bridgewater, New Jersey.
Daniel J. O'Connor
100 Somerset Corporate Boulevard, Bridgewater, NJ
1970